Search Results - "Amarenco, P."

The ASCOD phenotyping of ischemic stroke (Updated ASCO Phenotyping) by Amarenco, P, Bogousslavsky, J, Caplan, L R, Donnan, G A, Wolf, M E, Hennerici, M G

“…ASCO phenotyping (A: atherosclerosis; S: small-vessel disease; C: cardiac pathology; O: other causes) assigns a degree of likelihood of causal relationship to…”
Get more information

Classification of stroke subtypes by Amarenco, P, Bogousslavsky, J, Caplan, L R, Donnan, G A, Hennerici, M G

“…This article reviews published stroke subtype classification systems and offers rules and a basis for a new way to subtype stroke patients. Stroke subtyping…”
Get more information

Hemorrhagic stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels study by GOLDSTEIN, L. B, AMARENCO, P, SZAREK, M, CALLAHAN, A, HENNERICI, M, SILLESEN, H, ZIVIN, J. A, WELCH, K. M. A

“…In the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) study, atorvastatin 80 mg/day reduced the risk of stroke in patients with…”
Get full text

Mannheim carotid intima-media thickness and plaque consensus (2004-2006-2011). An update on behalf of the advisory board of the 3rd, 4th and 5th watching the risk symposia, at the 13th, 15th and 20th European Stroke Conferences, Mannheim, Germany, 2004, Brussels, Belgium, 2006, and Hamburg, Germany, 2011 by Touboul, P-J, Hennerici, M G, Meairs, S, Adams, H, Amarenco, P, Bornstein, N, Csiba, L, Desvarieux, M, Ebrahim, S, Hernandez Hernandez, R, Jaff, M, Kownator, S, Naqvi, T, Prati, P, Rundek, T, Sitzer, M, Schminke, U, Tardif, J-C, Taylor, A, Vicaut, E, Woo, K S

“…Intima-media thickness (IMT) provides a surrogate end point of cardiovascular outcomes in clinical trials evaluating the efficacy of cardiovascular risk factor…”
Get more information

New approach to stroke subtyping: the A-S-C-O (phenotypic) classification of stroke by Amarenco, P, Bogousslavsky, J, Caplan, L R, Donnan, G A, Hennerici, M G

“…We now propose a new approach to stroke subtyping. The concept is to introduce a complete 'stroke phenotyping' classification (i.e. stroke etiology and the…”
Get more information

Mannheim carotid intima-media thickness consensus (2004-2006). An update on behalf of the Advisory Board of the 3rd and 4th Watching the Risk Symposium, 13th and 15th European Stroke Conferences, Mannheim, Germany, 2004, and Brussels, Belgium, 2006 by Touboul, P-J, Hennerici, M G, Meairs, S, Adams, H, Amarenco, P, Bornstein, N, Csiba, L, Desvarieux, M, Ebrahim, S, Fatar, M, Hernandez Hernandez, R, Jaff, M, Kownator, S, Prati, P, Rundek, T, Sitzer, M, Schminke, U, Tardif, J-C, Taylor, A, Vicaut, E, Woo, K S, Zannad, F, Zureik, M

“…Intima-media thickness (IMT) is increasingly used as a surrogate end point of vascular outcomes in clinical trials aimed at determining the success of…”
Get more information

One-Year Risk of Stroke after Transient Ischemic Attack or Minor Stroke by Amarenco, P, Lavallee, P.C, Labreuche, J

Get full text

Mannheim intima-media thickness consensus by Touboul, P-J, Hennerici, M G, Meairs, S, Adams, H, Amarenco, P, Desvarieux, M, Ebrahim, S, Fatar, M, Hernandez Hernandez, R, Kownator, S, Prati, P, Rundek, T, Taylor, A, Bornstein, N, Csiba, L, Vicaut, E, Woo, K S, Zannad, F

“…Intima-media thickness (IMT) is increasingly used in clinical trials as a surrogate end point for determining the success of interventions that lower risk…”
Get more information

Blood—brain barrier disruption is associated with increased mortality after endovascular therapy by DESILLES, Jean-Philippe, ROUCHAUD, Aymeric, SIRIMARCO, Gaia, LAVALLEE, Philippa C, SCHOUMAN-CLAEYS, Elisabeth, AMARENCO, Pierre, MAZIGHI, Mikael, LABREUCHE, Julien, MESEGUER, Elena, LAISSY, Jean-Pierre, SERFATY, Jean-Michel, LAPERGUE, Bertrand, KLEIN, Isabelle F, GUIDOUX, Céline, CABREJO, Lucie

“…To evaluate the incidence, baseline characteristics, and clinical prognosis of blood-brain barrier (BBB) disruption after endovascular therapy in acute…”
Get full text

Early stroke risk and ABCD2 score performance in tissue- vs time-defined TIA: A multicenter study by GILES, M. F, ALBERS, G. W, JOHNSTON, S. C, KELLY, P. J, KIM, A. S, LABREUCHE, J, LAVALLEE, P. C, MAS, J.-L, MERWICK, A, OLIVOT, J. M, PURROY, F, ROSAMOND, W. D, AMARENCO, P, SCIOLLA, R, ROTHWELL, P. M, ARSAVA, E. M, ASIMOS, A. W, AY, H, CALVET, D, COUTTS, S. B, CUCCHIARA, B. L, DEMCHUK, A. M

“…Stroke risk immediately after TIA defined by time-based criteria is high, and prognostic scores (ABCD2 and ABCD3-I) have been developed to assist management…”
Get full text

Hypercholesterolemia, lipid-lowering agents, and the risk for brain infarction by Amarenco, P

“…Clinical trials in the 1990s using HMG-CoA reductase inhibitors (statins) showed that cholesterol-lowering treatment significantly reduces cardiovascular…”
Get full text

Clopidogrel Plus Aspirin Versus Warfarin in Patients With Stroke and Aortic Arch Plaques by Amarenco, P, Davis, S, Jones, E.F

Get full text

Atherothrombosis and the role of antiplatelet therapy by STEG, PH. G., DORMAN, S. H., AMARENCO, P.

“…Atherothrombosis remains a major global public health problem. Chronic atherosclerotic disease is often clinically silent and coexists across vascular beds,…”
Get full text

Effect of atorvastatin in elderly patients with a recent stroke or transient ischemic attack by CHARURVEDI, S, ZIVIN, J, BREAZNA, A, AMARENCO, P, CALLAHAN, A, GOLDSTEIN, L. B, HENNERICI, M, SILLESEN, H, RUDOLPH, A, WELCH, M. A

“…It is unclear whether patients age 65 years and over with a recent stroke or TIA benefit from statin treatment to a similar degree as younger patients. The…”
Get full text

In vivo middle cerebral artery plaque imaging by high-resolution MRI by KLEIN, I. F, LAVALLEE, P. C, TOUBOUL, P.-J, SCHOUMAN-CLAEYS, E, AMARENCO, P

“…Middle cerebral artery (MCA) atherosclerosis is currently diagnosed by indirect angiographic methods. The authors used high-resolution MRI (HR-MRI) to study…”
Get full text

Geographic differences in outcomes in outpatients with established atherothrombotic disease: results from the REACH Registry by Ducrocq, G, Bhatt, DL, Labreuche, J, Corbalan, R, Porath, A, Gao, R, Panchenko, E, Liau, CS, Ikeda, Y, Goto, S, Amarenco, P, Steg, PG

“…Aims There are major differences in the prevalence and management of patients with atherothrombotic disease including coronary artery disease (CAD),…”
Get full text

Multiple microembolic borderzone brain infarctions and endomyocardial fibrosis in idiopathic hypereosinophilic syndrome and in Schistosoma mansoni infestation by Sarazin, M, Caumes, E, Cohen, A, Amarenco, P

“…We report two cases of multiple distal borderzone ischaemic strokes associated with hypereosinophilia due to idiopathic hypereosinophilic syndrome in one…”
Get full text

Antithrombotic and thrombolytic therapy for ischemic stroke by Albers, G W, Amarenco, P, Easton, J D, Sacco, R L, Teal, P

Get more information

Predictors for malignant middle cerebral artery infarctions : A postmortem analysis by JARAMILLO, A, GONGORA-RIVERA, F, LABREUCHE, J, HAUW, J.-J, AMARENCO, P

“…Early detection of malignant infarction of the middle cerebral artery (MI-MCA) is important because of possible treatment by hemicraniectomy. To investigate…”
Get full text

Outcomes after thrombolysis in AIS according to prior statin use: A registry and review by MESEGUER, Elena, MAZIGHI, Mikael, OLIVOT, Jean-Marc, ROUCHAUD, Aymeric, DESILLES, Jean-Philippe, AMARENCO, Pierre, LAPERGUE, Bertrand, LABREUCHE, Julien, SIRIMARCO, Gaia, GONZALEZ-VALCARCEL, Jaime, LAVALLEE, Philippa C, CABREJO, Lucie, GUIDOUX, Céline, KLEIN, Isabelle F

“…The impact of prior statin use on outcomes after thrombolysis is unclear. We evaluated outcomes of patients treated by IV, intra-arterial (IA) thrombolysis, or…”
Get full text